BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 36552756)

  • 1. PICALM and Alzheimer's Disease: An Update and Perspectives.
    Ando K; Nagaraj S; Küçükali F; de Fisenne MA; Kosa AC; Doeraene E; Lopez Gutierrez L; Brion JP; Leroy K
    Cells; 2022 Dec; 11(24):. PubMed ID: 36552756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Picalm reduction exacerbates tau pathology in a murine tauopathy model.
    Ando K; De Decker R; Vergara C; Yilmaz Z; Mansour S; Suain V; Sleegers K; de Fisenne MA; Houben S; Potier MC; Duyckaerts C; Watanabe T; Buée L; Leroy K; Brion JP
    Acta Neuropathol; 2020 Apr; 139(4):773-789. PubMed ID: 31925534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of phosphatidylinositol clathrin assembly lymphoid-myeloid leukemia (PICALM) in intracellular amyloid precursor protein (APP) processing and amyloid plaque pathogenesis.
    Xiao Q; Gil SC; Yan P; Wang Y; Han S; Gonzales E; Perez R; Cirrito JR; Lee JM
    J Biol Chem; 2012 Jun; 287(25):21279-89. PubMed ID: 22539346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Level of PICALM, a key component of clathrin-mediated endocytosis, is correlated with levels of phosphotau and autophagy-related proteins and is associated with tau inclusions in AD, PSP and Pick disease.
    Ando K; Tomimura K; Sazdovitch V; Suain V; Yilmaz Z; Authelet M; Ndjim M; Vergara C; Belkouch M; Potier MC; Duyckaerts C; Brion JP
    Neurobiol Dis; 2016 Oct; 94():32-43. PubMed ID: 27260836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Role of PICALM in Alzheimer's Disease.
    Xu W; Tan L; Yu JT
    Mol Neurobiol; 2015 Aug; 52(1):399-413. PubMed ID: 25186232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreasing the expression of PICALM reduces endocytosis and the activity of β-secretase: implications for Alzheimer's disease.
    Thomas RS; Henson A; Gerrish A; Jones L; Williams J; Kidd EJ
    BMC Neurosci; 2016 Jul; 17(1):50. PubMed ID: 27430330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adaptor complex AP2/PICALM, through interaction with LC3, targets Alzheimer's APP-CTF for terminal degradation via autophagy.
    Tian Y; Chang JC; Fan EY; Flajolet M; Greengard P
    Proc Natl Acad Sci U S A; 2013 Oct; 110(42):17071-6. PubMed ID: 24067654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of PTB domain containing adaptor proteins on PICALM-mediated APP endocytosis and localization.
    Merthan L; Haller A; Thal DR; von Einem B; von Arnim CAF
    Biochem J; 2019 Jul; 476(14):2093-2109. PubMed ID: 31300465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clathrin adaptor CALM/PICALM is associated with neurofibrillary tangles and is cleaved in Alzheimer's brains.
    Ando K; Brion JP; Stygelbout V; Suain V; Authelet M; Dedecker R; Chanut A; Lacor P; Lavaur J; Sazdovitch V; Rogaeva E; Potier MC; Duyckaerts C
    Acta Neuropathol; 2013 Jun; 125(6):861-78. PubMed ID: 23589030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of clusterin, complement receptor 1, and phosphatidylinositol binding clathrin assembly protein in Alzheimer disease risk and cerebrospinal fluid biomarker levels.
    Schjeide BM; Schnack C; Lambert JC; Lill CM; Kirchheiner J; Tumani H; Otto M; Tanzi RE; Lehrach H; Amouyel P; von Arnim CA; Bertram L
    Arch Gen Psychiatry; 2011 Feb; 68(2):207-13. PubMed ID: 21300948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validating GWAS-Identified Risk Loci for Alzheimer's Disease in Han Chinese Populations.
    Wang HZ; Bi R; Hu QX; Xiang Q; Zhang C; Zhang DF; Zhang W; Ma X; Guo W; Deng W; Zhao L; Ni P; Li M; Fang Y; Li T; Yao YG
    Mol Neurobiol; 2016 Jan; 53(1):379-390. PubMed ID: 25452228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PICALM rs3851179 Variant Confers Susceptibility to Alzheimer's Disease in Chinese Population.
    Liu G; Xu Y; Jiang Y; Zhang L; Feng R; Jiang Q
    Mol Neurobiol; 2017 Jul; 54(5):3131-3136. PubMed ID: 27048444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genotype patterns at PICALM, CR1, BIN1, CLU, and APOE genes are associated with episodic memory.
    Barral S; Bird T; Goate A; Farlow MR; Diaz-Arrastia R; Bennett DA; Graff-Radford N; Boeve BF; Sweet RA; Stern Y; Wilson RS; Foroud T; Ott J; Mayeux R;
    Neurology; 2012 May; 78(19):1464-71. PubMed ID: 22539578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic association of PICALM polymorphisms with Alzheimer's disease in Han Chinese.
    Yu JT; Song JH; Ma T; Zhang W; Yu NN; Xuan SY; Tan L
    J Neurol Sci; 2011 Jan; 300(1-2):78-80. PubMed ID: 20951388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of GWAS top hits with late-onset Alzheimer disease in Korean population.
    Chung SJ; Lee JH; Kim SY; You S; Kim MJ; Lee JY; Koh J
    Alzheimer Dis Assoc Disord; 2013; 27(3):250-7. PubMed ID: 22975751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease.
    Harold D; Abraham R; Hollingworth P; Sims R; Gerrish A; Hamshere ML; Pahwa JS; Moskvina V; Dowzell K; Williams A; Jones N; Thomas C; Stretton A; Morgan AR; Lovestone S; Powell J; Proitsi P; Lupton MK; Brayne C; Rubinsztein DC; Gill M; Lawlor B; Lynch A; Morgan K; Brown KS; Passmore PA; Craig D; McGuinness B; Todd S; Holmes C; Mann D; Smith AD; Love S; Kehoe PG; Hardy J; Mead S; Fox N; Rossor M; Collinge J; Maier W; Jessen F; Schürmann B; Heun R; van den Bussche H; Heuser I; Kornhuber J; Wiltfang J; Dichgans M; Frölich L; Hampel H; Hüll M; Rujescu D; Goate AM; Kauwe JS; Cruchaga C; Nowotny P; Morris JC; Mayo K; Sleegers K; Bettens K; Engelborghs S; De Deyn PP; Van Broeckhoven C; Livingston G; Bass NJ; Gurling H; McQuillin A; Gwilliam R; Deloukas P; Al-Chalabi A; Shaw CE; Tsolaki M; Singleton AB; Guerreiro R; Mühleisen TW; Nöthen MM; Moebus S; Jöckel KH; Klopp N; Wichmann HE; Carrasquillo MM; Pankratz VS; Younkin SG; Holmans PA; O'Donovan M; Owen MJ; Williams J
    Nat Genet; 2009 Oct; 41(10):1088-93. PubMed ID: 19734902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence of the association of BIN1 and PICALM with the AD risk in contrasting European populations.
    Lambert JC; Zelenika D; Hiltunen M; Chouraki V; Combarros O; Bullido MJ; Tognoni G; Fiévet N; Boland A; Arosio B; Coto E; Del Zompo M; Mateo I; Frank-Garcia A; Helisalmi S; Porcellini E; Pilotto A; Forti P; Ferri R; Delepine M; Scarpini E; Siciliano G; Solfrizzi V; Sorbi S; Spalletta G; Ravaglia G; Valdivieso F; Alvarez V; Bosco P; Mancuso M; Panza F; Nacmias B; Bossù P; Piccardi P; Annoni G; Seripa D; Galimberti D; Licastro F; Lathrop M; Soininen H; Amouyel P
    Neurobiol Aging; 2011 Apr; 32(4):756.e11-5. PubMed ID: 21220176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between genetic risk factors and markers for Alzheimer's disease pathology.
    Elias-Sonnenschein LS; Bertram L; Visser PJ
    Biomark Med; 2012 Aug; 6(4):477-95. PubMed ID: 22917148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implication of a genetic variant at PICALM in Alzheimer’s disease patients and centenarians.
    Piaceri I; Bagnoli S; Lucenteforte E; Mancuso M; Tedde A; Siciliano G; Piacentini S; Bracco L; Sorbi S; Nacmias B
    J Alzheimers Dis; 2011; 24(3):409-13. PubMed ID: 21297266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Meta-analysis of the Association between Alzheimer Disease and Variants in GAB2, PICALM, and SORL1.
    Wang Z; Lei H; Zheng M; Li Y; Cui Y; Hao F
    Mol Neurobiol; 2016 Nov; 53(9):6501-6510. PubMed ID: 26611835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.